PMID- 37795364 OWN - NLM STAT- MEDLINE DCOM- 20231102 LR - 20231106 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 14 DP - 2023 TI - Ultrasound-guided microwave ablation in the treatment of recurrent primary hyperparathyroidism in a patient with MEN1: a case report. PG - 1175377 LID - 10.3389/fendo.2023.1175377 [doi] LID - 1175377 AB - BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1) is an inherited endocrine syndrome caused by the mutation in the tumor suppressor gene MEN1. The recurrence rate of primary hyperparathyroidism (PHPT) in patients with MEN1 after parathyroidectomy remains high, and the management of recurrent hyperparathyroidism is still challenging. CASE PRESENTATION: We reported a 44-year-old woman with MEN1 combined with PHPT who was diagnosed through genetic screening of the patient and her family members. After parathyroidectomy to remove one parathyroid gland, the patient suffered from persistent high levels of serum calcium and parathyroid hormone, which returned to normal at up to 8 months after ultrasound-guided microwave ablation (MWA) for bilateral parathyroid glands, suggesting an acceptable short-term prognosis. CONCLUSION: Ultrasound-guided MWA for parathyroid nodules may be an effective therapeutic strategy for recurrent PHPT in MEN1 patients. CI - Copyright (c) 2023 Liu, Zhao, Han, Hu, Zhang, Xu, Chen, Liu and Xu. FAU - Liu, Zhoujun AU - Liu Z AD - Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. FAU - Zhao, Yueting AU - Zhao Y AD - Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. FAU - Han, Xue AU - Han X AD - Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. FAU - Hu, Xin AU - Hu X AD - Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. FAU - Zhang, Yuzhi AU - Zhang Y AD - Department of Ultrasound, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. FAU - Xu, Lan AU - Xu L AD - Department of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China. FAU - Chen, Guofang AU - Chen G AD - Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. AD - Key Laboratory of Tradtional Chinese Medicine Syndrome & Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. FAU - Liu, Chao AU - Liu C AD - Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. AD - Key Laboratory of Tradtional Chinese Medicine Syndrome & Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. FAU - Xu, Shuhang AU - Xu S AD - Endocrine and Diabetes Center, The Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China. LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230919 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 SB - IM MH - Humans MH - Female MH - Adult MH - *Multiple Endocrine Neoplasia Type 1/complications/surgery/genetics MH - *Hyperparathyroidism, Primary/complications/diagnostic imaging/surgery MH - Microwaves/therapeutic use MH - Parathyroid Glands/diagnostic imaging/surgery/pathology MH - Ultrasonography, Interventional PMC - PMC10546301 OTO - NOTNLM OT - case report OT - microwave ablation OT - multiple endocrine neoplasia OT - primary hyperparathyroidism OT - recurrence COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/10/05 06:43 MHDA- 2023/11/02 12:46 PMCR- 2023/01/01 CRDT- 2023/10/05 04:10 PHST- 2023/02/27 00:00 [received] PHST- 2023/09/04 00:00 [accepted] PHST- 2023/11/02 12:46 [medline] PHST- 2023/10/05 06:43 [pubmed] PHST- 2023/10/05 04:10 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2023.1175377 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2023 Sep 19;14:1175377. doi: 10.3389/fendo.2023.1175377. eCollection 2023.